drugset / Trial / NCT00519259
Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to assess safety and pharmacokinetics of sublingual lobeline in healthy normal volunteers.
Timeline
- Start
- 2006-02
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lobeline | Small molecule | 30 mg | Other |
| Subject | Lobeline | Small molecule | 45 mg | Other |
| Subject | Lobeline | Small molecule | 60 mg | Other |